Medtronic reports 2.3% global revenue growth: 4 notes

Medtronic released an earnings report on Feb. 18 for the third quarter of fiscal year 2020, showing modest year-over-year revenue gains.

Four things to know:

1. The healthcare technology company reported $7.7 billion in global revenue for the three-month period ending Jan. 24. That total represents annual growth of 2.3 percent, led by more than 4 percent growth in its restorative therapies business.

2. In the U.S., Medtronic saw revenue gains of just 0.5 percent, to $4 billion, representing about 52 percent of the company's total revenue.

3. U.S. revenues were also led by about 4 percent growth in the restorative therapies group, while the minimally invasive therapies business reported 0.4 percent year-over-year growth. Both the cardiac and vascular group and diabetes group reported losses in revenue.

4. The quarter was a busy one for Medtronic: During the third quarter of its 2020 fiscal year, the company announced plans to acquire chronic pain treatment technology company Stimgenics, finalized its acquisition of artificial intelligence-enabled analytics software company Klue and formed a health IT partnership with Wilmington, Del.-based ChristianaCare.

More articles on health IT:
IBM Watson Health rolls out new clinical trial design software
Don't be a 'data pig' & 2 more ways to maintain trust while collecting patient data
7 alerts, tools hospitals are adding to their EHRs

© Copyright ASC COMMUNICATIONS 2021. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.